Brain Development Cohorts (NBDC) and Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for researchers seeking access to biospecimens and data from NIH's major longitudinal cohort studies. Eligible applicants include universities, research institutions, nonprofits, and independent researchers with valid institutional affiliations. Applicants must propose research using biospecimens from NIH Brain Development Cohorts or PATH Study populations. Studies must have scientific merit and comply with all data use agreements and ethical requirements. Geographic scope is nationwide; funded research may occur anywhere in the United States.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- Sep 10, 2025 Applications open
- Sep 8, 2026 Application deadline in 53 days
- Jan 4, 2027 Award announced
- Jan 4, 2027 Project start
Program description
The National Institute on Drug Abuse seeks to advance its mission by providing the scientific community with the opportunity to request access to biospecimens from the Adolescent Brain Cognitive Development (ABCD) Study, the HEALthy Brain and Child Development (HBCD) Study, and the Population Assessment of Tobacco and Health (PATH) Study to conduct research consistent with study objectives that will maximize the scientific utility of these limited samples. Research proposals should expand the knowledge gained from these studies and advance our understanding the multiple genetic and environmental factors, including exposure to substances, that affect health and disease over the course of a lifetime. Grant authorities that allow NIH to forecast this opportunity are as follows Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Part 75 and 2 CFR Part 200].
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Application for Federal Assistance)
- Project Narrative/Research Plan
- Budget and Budget Justification
- Curriculum Vitae (senior personnel)
- Data Use Agreement or Acknowledgment
- Institutional Endorsement Letter
Program contact
- 👤 Heather L. Kimmel
- 📧 heather.kimmel@nih.gov
- 📞 301-443-6504
Funding track record
Recent awards under CFDA 93.279 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$204,359,786
-
$128,078,833
-
$126,585,435
-
$99,478,296
-
$79,333,238
-
$78,351,755
-
$74,806,844
-
$71,588,047
-
$61,578,651
-
$50,952,037
Top States by Funding
- NY 4 awards $260.8M
- WA 1 awards $204.4M
- CT 2 awards $155.8M
- CA 4 awards $141.1M
- MD 2 awards $128.2M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.279). How funding has trended year over year.
| 2024 | $1,245,503,136 | |
| 2025 | $1,343,517,098 | |
| 2026 est. | $20,194,375 |
FAQ
Who can apply for biospecimen access?
Researchers with institutional affiliation at universities, medical centers, nonprofits, and research institutions. Independent researchers typically need sponsorship from an eligible institution.
What types of research are funded?
Studies using biospecimens and data from NBDC or PATH Study populations for health-related research. Observational studies, secondary data analysis, and clinical research are supported.
What is the typical funding range?
This is primarily a biospecimen access program. Direct funding for projects varies; many use existing cohort data without additional grants.
How competitive is this program?
Competition varies by research topic and data availability. Well-designed studies with clear scientific rationale are favored.
When are applications due?
Specific deadlines vary by funding cycle. Check NIH Grants.gov for current opening and closing dates for this CFDA.
💡 Tips for applicants
- Clearly justify why NBDC or PATH Study biospecimens are essential for your research question.
- Demonstrate familiarity with the cohort's population, available biospecimens, and data elements.
- Address data privacy and ethical compliance explicitly in your proposal.
- Coordinate with cohort administrators early to confirm sample availability and access requirements.
- Submit a realistic timeline that accounts for biospecimen processing and data access procedures.
⚠️ Common mistakes
Applicants fail to confirm biospecimen availability before submitting. Proposals lack specific scientific hypotheses about biomarkers or health outcomes. Studies don't adequately address confidentiality and IRB requirements for secondary data use.
Similar grants
- OPEN Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01) — National Institutes of Health
- OPEN Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Access (X01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Limited Competition for the Continuation of the National Consortium on Alcohol and Neurodevelopment in Adolescence (NCANDA) Data Analysis Resource (U24 Clinical Trials Optional) — National Institutes of Health
- OPEN Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Exposomic Contributions to ADRD Pathology and Resilience — National Institutes of Health